Literature DB >> 2605965

Choosing covariates in the analysis of clinical trials.

M L Beach1, P Meier.   

Abstract

Much of the literature on clinical trials emphasizes the importance of adjusting the results for any covariates (baseline variables) for which randomization fails to produce nearly exact balance, but the literature is very nearly devoid of recipes for assessing the consequences of such adjustments. Several years ago, Paul Canner presented an approximate expression for the effect of a covariate adjustment, and he considered its use in the selection of covariates. With the aid of Canner's equation, using both formal analysis and simulation, the impact of covariate adjustment is further explored. Unless tight control over the analysis plans is established in advance, covariate adjustment can lead to seriously misleading inferences. Illustrations from the clinical trials literature are provided.

Mesh:

Year:  1989        PMID: 2605965     DOI: 10.1016/0197-2456(89)90055-x

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  14 in total

1.  Prognostic factors in clinical trials.

Authors:  S Dahlberg; P Y Liu
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  The impact of covariate adjustment at randomization and analysis for binary outcomes: understanding differences between superiority and noninferiority trials.

Authors:  Katherine Nicholas; Sharon D Yeatts; Wenle Zhao; Jody Ciolino; Keith Borg; Valerie Durkalski
Journal:  Stat Med       Date:  2015-02-02       Impact factor: 2.373

Review 3.  Acute hypertensive response in patients with intracerebral hemorrhage pathophysiology and treatment.

Authors:  Adnan I Qureshi; Mushtaq H Qureshi
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-16       Impact factor: 6.200

4.  Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale.

Authors:  A I Qureshi; Y Y Palesch
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

5.  New considerations in the design of clinical trials for traumatic brain injury.

Authors:  Bob Roozenbeek; Hester F Lingsma; Andrew Ir Maas
Journal:  Clin Investig (Lond)       Date:  2012-02

6.  Stakeholder benefit from depression disease management: differences by rurality?

Authors:  Stanley Xu; Kathryn Rost; Fran Dong; L Miriam Dickinson
Journal:  J Behav Health Serv Res       Date:  2010-01-06       Impact factor: 1.505

7.  Augmenting usual care SSRIs with cognitive behavioral therapy for insomnia to improve depression outcomes in youth: Design of a randomized controlled efficacy-effectiveness trial.

Authors:  Greg Clarke; Christina R Sheppler; Alison J Firemark; Andreea M Rawlings; John F Dickerson; Michael C Leo
Journal:  Contemp Clin Trials       Date:  2020-02-28       Impact factor: 2.226

8.  Pancreatitis, very early compared with normal start of enteral feeding (PYTHON trial): design and rationale of a randomised controlled multicenter trial.

Authors:  Olaf J Bakker; Hjalmar C van Santvoort; Sandra van Brunschot; Usama Ahmed Ali; Marc G Besselink; Marja A Boermeester; Thomas L Bollen; Koop Bosscha; Menno A Brink; Cornelis H Dejong; Erwin J van Geenen; Harry van Goor; Joos Heisterkamp; Alexander P Houdijk; Jeroen M Jansen; Thom M Karsten; Eric R Manusama; Vincent B Nieuwenhuijs; Bert van Ramshorst; Alexander F Schaapherder; George P van der Schelling; Marcel Bm Spanier; Adriaan Tan; Juda Vecht; Bas L Weusten; Ben J Witteman; Louis M Akkermans; Hein G Gooszen
Journal:  Trials       Date:  2011-03-10       Impact factor: 2.279

9.  Bias, precision and statistical power of analysis of covariance in the analysis of randomized trials with baseline imbalance: a simulation study.

Authors:  Bolaji E Egbewale; Martyn Lewis; Julius Sim
Journal:  BMC Med Res Methodol       Date:  2014-04-09       Impact factor: 4.615

10.  Empirical comparison of four baseline covariate adjustment methods in analysis of continuous outcomes in randomized controlled trials.

Authors:  Shiyuan Zhang; James Paul; Manyat Nantha-Aree; Norman Buckley; Uswa Shahzad; Ji Cheng; Justin DeBeer; Mitchell Winemaker; David Wismer; Dinshaw Punthakee; Victoria Avram; Lehana Thabane
Journal:  Clin Epidemiol       Date:  2014-07-14       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.